Announcements Trials

Browse Landscape

Phase

Phase 3 11 Phase NA 6 Phase 2 4 Phase 4 1

Status

Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 1 Hodgkin Disease 1

Interventions

Zoledronic Acid 28 Saline Solution 26 Metformin 25 Dexamethasone 25 Cyclophosphamide 23 Cytarabine 22 Bupivacaine 20 Sodium Chloride 18 Vincristine 17 Methotrexate 17 Letrozole 17 Propofol 15 Morphine 15 Doxorubicin 15 Cisplatin 15 Prednisolone 14 Docetaxel 14 Dexmedetomidine 14 Bevacizumab 14 Oxycodone 13 Imiquimod 13 Fentanyl 13 Capecitabine 13 Rituximab 12 Mercaptopurine 12 Fluorouracil 12 Granulocyte Colony-Stimulating Factor 11 Everolimus 11 Asparaginase 11 Acetaminophen 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Completed × Watchful Waiting × Clear all

NCT01088750 2023-12-13

EuroNetLP1

Martin-Luther-Universität Halle-Wittenberg

Phase 4 Completed

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡